News

Expand filters

Filters

Showing 1 - 4 out of 4 results

News

FOX4: Saint Luke's and UMKC Leading Nationwide Study on Pregnant People with Heart Conditions

The NIH awarded more than $8.3 million to study 1,000 pregnant individuals with heart conditions in an effort to combat maternal mortality and morbidity.

News

Ingram's: Saint Luke’s, UMKC Partner on Four-Year Study to Combat Maternal Mortality

The four-year observational study will research U.S. pregnant people with cardiovascular disease to better understand and combat maternal mortality and morbidity.

News

BBC News: Studies Reveal New Effects of Semaglutide

BBC News talked to Dr. Mikhail Kosiborod about new findings on the cardiovascular effects of semaglutide.

Article

American Journal of Managed Care: Semaglutide Enhances Heart Failure Outcomes in Obesity

A new subanalysis presented by Dr. Mikhail Kosiborod shows benefits of semaglutide in patients with atrial fibrillation.